Lindbrook Capital, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 157 shares of RARE stock, worth $7,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157

Previous 79 98.73%

Holding current value

$7,025

Previous $3,000 166.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$40.21 - $59.36 $3,136 - $4,630	78 Added 98.73%	157 $8,000
Q2 2024 Jul 31, 2024	SELL	$37.42 - $51.61 $1,421 - $1,961	-38 Reduced 32.48%	79 $3,000
Q1 2024 Apr 25, 2024	BUY	$43.02 - $53.69 $774 - $966	18 Added 18.18%	117 $5,000
Q4 2023 Jan 31, 2024	BUY	$31.73 - $49.19 $444 - $688	14 Added 16.47%	99 $4,000
Q3 2023 Oct 25, 2023	SELL	$34.92 - $46.66 $4,714 - $6,299	-135 Reduced 61.36%	85 $3,000
Q2 2023 Jul 28, 2023	BUY	$37.35 - $52.15 $1,045 - $1,460	28 Added 14.58%	220 $10,000
Q1 2023 Apr 26, 2023	SELL	$36.99 - $48.71 $9,173 - $12,080	-248 Reduced 56.36%	192 $7,000
Q4 2022 Jan 24, 2023	BUY	$33.72 - $46.33 $10,992 - $15,103	326 Added 285.96%	440 $0
Q3 2022 Nov 10, 2022	BUY	$39.96 - $66.14 $4,555 - $7,539	114 New	114 $5,000
Q2 2022 Aug 01, 2022	SELL	$45.8 - $85.4 $1,282 - $2,391	-28 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$62.2 - $84.4 $248 - $337	4 Added 16.67%	28 $2,000
Q4 2021 Jan 18, 2022	BUY	$73.71 - $87.86 $1,769 - $2,108	24 New	24 $2,000
Q2 2021 Jul 27, 2021	SELL	$92.19 - $115.71 $645 - $809	-7 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$106.9 - $167.73 $748 - $1,174	7 New	7 $1,000
Q1 2020 Apr 22, 2020	SELL	$33.8 - $62.9 $574 - $1,069	-17 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$36.08 - $45.83 $2,525 - $3,208	-70 Reduced 80.46%	17 $1,000
Q3 2019 Oct 31, 2019	BUY	$42.5 - $63.11 $1,020 - $1,514	24 Added 38.1%	87 $4,000
Q4 2018 Feb 07, 2019	BUY	$38.89 - $77.3 $2,450 - $4,869	63 New	63 $2,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Ultragenyx Pharmaceutical Inc. Transaction History